A clinical study evaluating dendritic and cytokine-induced killer cells combined with concurrent radiochemotherapy for stage IIIB non-small cell lung cancer.
作者： X.P. Zhu , Y.H. Xu , J. Zhou , X.F. Pan
关键词:
摘要: To compare the efficacy of dendritic and cytokine-induced killer cells (DC-CIK) therapy combined with concurrent radiochemotherapy on stage IIIB non-small cell lung cancer. Sixty-three patients cancer were randomly divided into study control groups. The group, comprising 30 patients, was treated DC-CIK docetaxel-cisplatin chemotherapy synchronization conformal radiotherapy. group including 33 only efficacy, Karnofsky performance score (KPS), tumor markers, 6-month 12-month survival rate, T subsets, adverse reactions two groups compared. response rate 83.3% (25/30), that 54.5% (18/33). Furthermore, KPS, significantly higher in there significant differences between had no difference reactions. therapy, synchronous radiotherapy to treat superior single chemotherapy. can improve life quality prolong time patients.
funpecrp.com.br 
sci-hub.st 参考文章(14)
Monica R. Hazelrigg, Jerry I. Hirsch, Randall E. Merchant, Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat. Journal of Neuro-oncology. ,vol. 60, pp. 143- 150 ,(2002) , 10.1023/A:1020684732685
Xiuyi Zhi, Wen Gao, Baohui Han, Yue Yang, Hui Li, Deruo Liu, Changli Wang, Gong Min, Hao Long, James R Rigas, Mark Carey, Thierry Jahan, Amanda Sammann, Joseph Reza, Daoyuan Wang, Michael J Mann, David M Jablons, Jianxing He, China Clinical Trials Consortium, VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer. Journal of Thoracic Disease. ,vol. 5, pp. 578- 584 ,(2013) , 10.3978/J.ISSN.2072-1439.2012.02.05
Yoshiaki Tsuchida, Patrick Therasse, Response evaluation criteria in solid tumors (RECIST): new guidelines. Medical and Pediatric Oncology. ,vol. 37, pp. 1- 3 ,(2001) , 10.1002/MPO.1154
J. Casal Rubio, J. L. Fírvida-Pérez, M. Lázaro-Quintela, F. J. Barón-Duarte, G. Alonso-Jáudenes, L. Santomé, F. J. Afonso-Afonso, M. Amenedo, G. Huidobro, B. Campos-Balea, M. D. López-Vázquez, S. Vázquez, A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non‑small‑cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study Cancer Chemotherapy and Pharmacology. ,vol. 73, pp. 451- 457 ,(2014) , 10.1007/S00280-013-2370-Z
Alex Chang, Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC Lung Cancer. ,vol. 71, pp. 3- 10 ,(2011) , 10.1016/J.LUNGCAN.2010.08.022
Koichi Takayama, Koji Inoue, Shoji Tokunaga, Takemasa Matsumoto, Tsukasa Oshima, Masayuki Kawasaki, Tomotoshi Imanaga, Mutsuo Kuba, Masafumi Takeshita, Taishi Harada, Yoshiyuki Shioyama, Yoichi Nakanishi, Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401 Cancer Chemotherapy and Pharmacology. ,vol. 72, pp. 1353- 1359 ,(2013) , 10.1007/S00280-013-2335-2
Mohammad Mehrian, Davud Asemani, Abazar Arabameri, Arash Pourgholaminejad, Jamshid Hadjati, Research article: Modeling of tumor growth in dendritic cell-based immunotherapy using artificial neural networks Computational Biology and Chemistry. ,vol. 48, pp. 21- 28 ,(2014) , 10.1016/J.COMPBIOLCHEM.2013.09.007
Lili Yang, Baozhu Ren, Hui Li, Jinpu Yu, Shui Cao, Xishan Hao, Xiubao Ren, None, Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients Cancer Immunology, Immunotherapy. ,vol. 62, pp. 65- 73 ,(2013) , 10.1007/S00262-012-1311-8
José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, Joo-Hang Kim, Helen Barraclough, Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Drugs in R & D. ,vol. 13, pp. 289- 296 ,(2013) , 10.1007/S40268-013-0032-6
Alessandra Bearz, Emilio Minatel, Imad Abu Rumeileh, Eugenio Borsatti, Renato Talamini, Giovanni Franchin, Carlo Gobitti, Alessandro Del Conte, Marco Trovò, Tanja Baresic, Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen BMC Cancer. ,vol. 13, pp. 513- 513 ,(2013) , 10.1186/1471-2407-13-513